Abstract
Successful management of Retinoblastoma (RB) depends on the ability to detect the disease while still being intraocular and non-disseminated. The dissemination of RB may occur to the central nervous system and/or through hematologic dissemination, but imaging and cytology studies are not able to detect very low levels of disease. Molecular identification of specific tumor markers may incr…